These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34568359)

  • 21. The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients.
    Haufroid V; Mourad M; Van Kerckhove V; Wawrzyniak J; De Meyer M; Eddour DC; Malaise J; Lison D; Squifflet JP; Wallemacq P
    Pharmacogenetics; 2004 Mar; 14(3):147-54. PubMed ID: 15167702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bisoprolol/amlodipine combination therapy improves blood pressure control in patients with essential hypertension following monotherapy failure.
    Gottwald-Hostalek U; Li L; Montenegro P
    Curr Med Res Opin; 2016 Oct; 32(10):1735-1743. PubMed ID: 27334671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Influence of EGCG on the Pharmacokinetics and Pharmacodynamics of Bisoprolol and a New Method for Simultaneous Determination of EGCG and Bisoprolol in Rat Plasma.
    Zeng W; Lao S; Guo Y; Wu Y; Huang M; Tomlinson B; Zhong G
    Front Nutr; 2022; 9():907986. PubMed ID: 35711541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bisoprolol, a once-a-day beta-blocking agent for patients with mild to moderate hypertension.
    Davidov ME; Singh SP; Vlachakis ND; Blumenthal JB; Simon JS; Bryzinski BS; Koury KJ; Alemayehu D
    Clin Cardiol; 1994 May; 17(5):263-8. PubMed ID: 8004841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of antihypertensive effect by blood pressure monitoring: applications to bisoprolol and lisinopril in a double-blind study.
    Vaïsse B; Herpin D; Asmar R; Battistella P; Zannad F; Boutelant S; Lyon A; Conte D; Denis J; Honore P; Contard S; Prost PL; Mallion JM; Poggi L
    J Cardiovasc Pharmacol; 1997 May; 29(5):612-7. PubMed ID: 9213203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantification of the steady-state plasma concentrations of clozapine and N-desmethylclozapine in Japanese patients with schizophrenia using a novel HPLC method and the effects of CYPs and ABC transporters polymorphisms.
    Akamine Y; Sugawara-Kikuchi Y; Uno T; Shimizu T; Miura M
    Ann Clin Biochem; 2017 Nov; 54(6):677-685. PubMed ID: 27932669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Factors predicting blood pressure normalization in hypertensive patients treated with a fixed-dose combination of bisoprolol 2.5 mg/hydrochlorothiazide/6.25 mg].
    Girerd X; Mosnier M
    Arch Mal Coeur Vaiss; 2003; 96(7-8):776-9. PubMed ID: 12945222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
    Keam SJ; Keating GM
    Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypotensive and heart rate-lowering effects of low-dose bisoprolol determined based on self-measured blood pressure at home.
    Satoh M; Obara T; Ikeda U; Kobayashi Y; Metoki H; Asayama K; Kikuya M; Ohkubo T; Imai Y
    Clin Exp Hypertens; 2012; 34(4):284-9. PubMed ID: 22571411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: a placebo-controlled, forced titration study. Candesartan/Losartan study investigators.
    Lacourcière Y; Asmar R
    Am J Hypertens; 1999 Dec; 12(12 Pt 1-2):1181-7. PubMed ID: 10619580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of CYP3A5 and MDR1 (ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients.
    Tsuchiya N; Satoh S; Tada H; Li Z; Ohyama C; Sato K; Suzuki T; Habuchi T; Kato T
    Transplantation; 2004 Oct; 78(8):1182-7. PubMed ID: 15502717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer.
    Wegman P; Elingarami S; Carstensen J; Stål O; Nordenskjöld B; Wingren S
    Breast Cancer Res; 2007; 9(1):R7. PubMed ID: 17244352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of CYP3A4*1G and CYP3A5*3 polymorphisms on pharmacokinetics of tylerdipine hydrochloride in healthy Chinese subjects.
    Zhou S; Tao M; Wang Y; Wang L; Xie L; Chen J; Zhao Y; Liu Y; Zhang H; Ou N; Wang G; Shao F; Aa J
    Xenobiotica; 2019 Mar; 49(3):375-380. PubMed ID: 29521134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The clinical efficiency and safety of bisoprolol hydrochlorothiazide in patients with mild to moderate essential hypertension].
    Jiang H; Ke YN;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jul; 34(7):605-8. PubMed ID: 17081362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of MDR1 and CYP3A5 genetic polymorphisms on trough levels and therapeutic response of imatinib in newly diagnosed patients with chronic myeloid leukemia.
    Harivenkatesh N; Kumar L; Bakhshi S; Sharma A; Kabra M; Velpandian T; Gogia A; Shastri SS; Biswas NR; Gupta YK
    Pharmacol Res; 2017 Jun; 120():138-145. PubMed ID: 28330783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of CYP2D6, CYP3A5, CYP2C19, CYP2A6, SLCO1B1, ABCB1, and ABCG2 gene polymorphisms on the pharmacokinetics of simvastatin and simvastatin acid.
    Choi HY; Bae KS; Cho SH; Ghim JL; Choe S; Jung JA; Jin SJ; Kim HS; Lim HS
    Pharmacogenet Genomics; 2015 Dec; 25(12):595-608. PubMed ID: 26367500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of
    Yaowaluk T; Senanarong V; Limwongse C; Boonprasert R; Kijsanayotin P
    Pharmgenomics Pers Med; 2019; 12():209-224. PubMed ID: 31564952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Efficacy and safety of bisoprolol in pregnant women with chronic arterial hypertension do not depend on genetic CYP2D6 polymorphism].
    Brytkova IaV; Ignat'ev IV; Kazakov RE; Sokova EA; Striuk RI
    Kardiologiia; 2009; 49(7-8):50-5. PubMed ID: 19656108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of antihypertensive drug responses: initial data from a placebo-controlled, randomized, cross-over study with four antihypertensive drugs (The GENRES Study).
    Hiltunen TP; Suonsyrjä T; Hannila-Handelberg T; Paavonen KJ; Miettinen HE; Strandberg T; Tikkanen I; Tilvis R; Pentikäinen PJ; Virolainen J; Kontula K
    Am J Hypertens; 2007 Mar; 20(3):311-8. PubMed ID: 17324745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bisoprolol in the treatment of hypertension in the elderly.
    Broncel M; Chojnowska-Jezierska J; Adamska-Dyniewska H
    J Hum Hypertens; 1998 Sep; 12(9):643-4. PubMed ID: 9783498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.